A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children

Clinical Therapeutics

Volumn 18, Issue 1, 1996, Pages 160-182

  Oh, Paul I ^a   Maerov, Phillip ^a   Pritchard, Daniel ^a   Knowles, Sandra R ^a   Einarson, Thomas R ^b   Shear, Neil H ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFACLOR; PEDIAZOLE;

ACUTE DISEASE; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; MALE; META ANALYSIS; OTITIS MEDIA; PEDIATRICIAN; PHYSICIAN; QUALITY OF LIFE; SKIN TOXICITY; TREATMENT OUTCOME;

EID: 0029848808     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80188-3     Document Type: Article

References (69)

1. Rosenfeld RM, Vertes JE, Carr J. et al. Clinical efficacy of antimicrobial drugs for acute otitis media: Meta-analysis of 5400 children from thirty-three randomized trials. J Pediatr. 1994;124:355-367.
2. Stool SE, Field MJ. The impact of acute otitis media. Pediatr Infect Dis J. 1989;8: 511-514.
3. Bluestone CD. Management of otitis media in infants and children: Current role of old and new antimicrobial agents. Pediatr Infect Dis J. 1988;7(Suppl):S129-S136.
4. Kligman EW. Treatment of otitis media. Am Fam Phys. 1992;45:242-250.
5. Giebink GS, Canafax DM. Antimicrobial treatment of acute otitis media. Semin Respir Infect. 1991;6:85-93.
6. Henderson FW, Gilligan PH, Wait K, et al. Nasopharyngeal carriage of antibiotic resistant pneumococci by children in group day care. J Infect Dis. 1988;157: 256-263.
7. Pichichero ME. Assessing the treatment alternatives for acute otitis media. Pediatr Infect Dis J. 1994;13(Suppl):S27-S34.
8. Noel FL. Looking into the clinical picture of otitis media. Can J Diagn. 1993;2: 27-47.
9. Ontario Anti-Infectives Review Panel. Ontario Anti-Infective Guidelines. Ontario Ministry of Health, 1994:9.
10. McCombs TS, Nichol MB. The use of first- and second-line outpatient antibiotics under the Saskatchewan drug plan. Pharmacoeconomics. 1995;7:543-554.
11. Berman S. Otitis media in children. NEJM. 1995;332:1560-1565.
12. Aspin MM, Hoberman A, McCarty J, et al. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J Pediatr. 1994; 125:136-141.
13. Harrison CJ, Chartrand SA, Pichichero ME. Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children. Pediatr Infect Dis J. 1993;12:62-69.
14. Rodriguez WJ, Khan W, Sait T, et al. Cefixime vs. cefaclor in the treatment of acute otitis media in children: A randomized, comparative study. Pediatr Infect Dis J. 1993;12:70-74.
15. Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother. 1993;31:81-88.
16. Jacobsson S, Fogh A, Larsson P, Lomborg S. Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Eur J Clin Microbiol Infect Dis. 1993;12: 319-324.
17. Foshee WS. Loracarbef (LY 163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion. J Pediatr. 1992;120:980-986.
18. Pestalozza G, Coice C, Facchini M. Azithromycin in upper respiratory tract infections: A clinical trial in children with otitis media. Scand J Infect Dis. 1992; 83(Suppl):22-25.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177-188.
20. Heckbert SR, Stryker WS, Coltin KL, et al. Serum sickness in children after antibiotic exposure: Estimates of occurrence and morbidity in a health maintenance organization population. Am J Epidemiol. 1990;132:336-342.
21. Platt R, Dreis MW, Kennedy DL, Kuritsky JN. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole. J Infect Dis. 1988;158:474-476.
22. Levine LR. Quantitative comparison of adverse reactions to cefaclor vs. amoxicillin in a surveillance study. Pediatr Infect Dis J. 1985;4:358-361.
23. Mandel EM, Bluestone BH, Cantekin EI, et al. Comparison of cefaclor and amoxicillin for acute otitis media with effusion. Ann Otol Rhinol Laryngol. 1981;90: 48-52.
24. Marchant CD. Shurin PA. Johnson CE, et al. A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment in acute otitis media. J Pediatr. 1986;109:891-896.
25. Marchant CD, Shurin PA, Turcyzk VA, et al. A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media. J Pediatr. 1984;105:633-638.
26. Feldman W, Richardson H, Rennie B, Dawson P. A trial comparing cefaclor with co-trimoxazole for the treatment of acute otitis media. Arch Dis Child. 1982:57: 594-596.
27. Mandel EM, Bluestone CD, Rockette HE, et al. Duration of effusion after antibiotic treatment for acute otitis media: Comparison of cefaclor and amoxicillin. Pediatr Infect Dis J. 1982;1:310-316.
28. McLinn SE. Cefaclor in treatment of otitis media and pharyngitis in children. Am J Dis Child. 1980;134:560-563.
29. Jacobson JA, Parkin JL, Metcalf TJ, et al. Evaluation of cefaclor and amoxicillin in the treatment of acute otitis media. Postgrad Med J. 1979;55(Suppl 4):39-41.
30. Blumer JL, Bertino JS Jr, Husak MP. Comparison of cefaclor and trimethoprim-sulfamethoxazole in the treatment of acute otitis media. Pediatr Infect Dis J. 1984;3: 25-29.
31. Tarpay M, Marks MI, Hopkins C, et al. Cefaclor therapy twice daily for acute otitis media. Controlled comparative study of twice-daily vs. thrice daily dose schedule. Am J Dis Child. 1982;136:33-35.
32. Biolcati AH. An open comparative study of the efficacy and safety of sultimicillin versus cefaclor in the treatment of acute otitis media in children. J Int Med Res. 1992;20:31A-43A.
33. Odio CM, Kusmiesz H, Shelton S. Nelson JD. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion. Pediatrics. 1985;75: 819-826.
34. Gooch WM III, Gan VN, Corder WT, et al. Clarithromycin and cefaclor suspensions in the treatment of acute otitis media in children. Pediatr Infect Dis J. 1993;12:S128-S133.
35. Quevedo A, Sossouhounto R, Kissling M. Cefetamet pivoxil in otitis media. Orl J Otorhinolaryngol Relat Spec. 1993;55: 93-96.
36. Kramer MS, Hutchinson TA, Naimark L, et al. Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients. Pediatrics. 1985;76:365-370.
37. Pichichero ME, Aronovitz GH, Gooch WM III, et al. Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children. South Med J. 1990;83:1174-1176.
38. Stutman HR, Arguedas AG. Comparison of cefprozil and other antibiotic regimens in the treatment of children with acute otitis media. Clin Infect Dis. 1992;14(Suppl 2):S204-S208.
39. Kaprio E, Haapaniemi J, Bondesson G. Clinical efficacy of amoxicillin/clavulanic acid and cefaclor in acute otitis media. Acta Oto-Laryngol. 1988;449:45-46.
40. Kaleida PH, Bluestone BH, Rockette HE, et al. Amoxicillin-clavulanate potassium compared with cefaclor for acute otitis media in infants and children. Pediatr Infect Dis J. 1987;6:265-271. (Erratum appears in Pediatr Infect Dis J. 1987;6:734.)
41. Jacobsson S, Rigner P, von Sydow C, Bondesson G. Recurrent and penicillin V-resistant otitis media. A treatment study with amoxicillin/clavulanate and cefaclor. Acta Oto-Laryngol. 1988;106:171-177.
42. John WR, Valle-Jones JC. Treatment of otitis media in children. A comparison between cefaclor and amoxicillin. Practitioner. 1983;227:1805-1809.
43. Giebink GS, Batalden PB, Russ JN, Le CT. Cefaclor v. amoxicillin in treatment of acute otitis media. Am J Dis Child. 1984;138:287-292.
44. Pukander JS, Paloheimo SH, Sipila MM. Cefetamet pivoxil in pediatric otitis media. Chemotherapy. 1992;38:25-28.
45. Piippo T, Stefansson S, Pitkajarvi T, Lundberg C. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children. Scand J Infect Dis. 1991;23:459-465.
46. Donaldson JD, Martin GF, Maltby CC, Seywerd EB. The efficacy of pulse-dosed antibiotic therapy in the management of persistent otitis media with effusion. J Otolaryngol. 1990;19:175-178.
47. Aronovitz GH. Treatment of otitis media with cefuroxime axetil. South Med J. 1988;81:978-980.
48. Kenna MA, Bluestone CD, Fall P, et al. Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children. Pediatr Infect Dis J. 1987;6:992-996.
49. Bergeron MG, Ahronheim G, Richard JE, et al. Comparative efficacies of erythromycin-sulfisoxizole and cefaclor in acute otitis media: A double-blind randomized trial. Pediatr Infect Dis J. 1987;6: 654-660.
50. Feldman W, Sutcliffe T, Dulberg C. Twice-daily antibiotics in the treatment of acute otitis media: Trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate. Can Med Assoc J. 1990;142:115-118.
51. McCarty J. Comparative safety and efficacy of clarithromycin and amoxicillin/ clavulanate in the treatment of acute otitis media in children. Pediatr Infect Dis J. 1993;12(Suppl 3):S122-S127.
52. Arguedas AG, Zaleska M, Stutman HR, et al. Comparative trial of cefprozil vs. amoxicillin-clavulanate potassium in the treatment of children with acute otitis media with effusion. Pediatr Infect Dis J. 1991;10:375-380.
53. Chan KH, Mandel EM, Rockette HE, et al. A comparative study of amoxicillin-clavulanate and amoxicillin. Treatment of otitis media with effusion. Arch Otolaryngol Head Neck Surg. 1988;114:142-146.
54. Stenstrom C, Lundgren K, Ingvarsson L, Bertilson SO. Amoxicillin/clavulanate versus amoxicillin in recurrent otitis media and therapeutic failure in children. Acta Oto-Laryngol. 1991;111:120-129.
55. Chan KH, Bluestone CD, Tan LS, et al. Comparative study of sultamicillin and amoxicillin-clavulanate: Treatment of acute otitis media. Pediatr Infect Dis J. 1993;12:24-28.
56. Gehanno P, Taillebe M, Denis P, et al. Short-course cefotaxime compared with five day co-amoxyclav in acute otitis media in children. J Antimicrob Chemother. 1990;26:29-36.
57. Daniel RR. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children. J Antimicrob Chemother. 1993;31:65-71.
58. Can VN, Kusmiesz, H, Shelton S, Nelson JD. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media. Antimicrob Agents Chemother. 1991;35:967-971.
59. Mendelman PM, Del Beccaro MA, McLinn SE, Todd WM. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media. J Pediatr. 1992;121:459-465. (Erratum appears in J Pediatr. 1993;122:502.)
60. McLinn SE, Moskal M, Goldfarb J, et al. Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother. 1994;38:315-318.
61. Rodriguez WJ, Schwartz RH, Sait T, et al. Erythromycin-sulfisoxazole vs amoxicillin in the treatment of acute otitis media in children. A double-blind, multiple-dose comparative study. Am J Dis Child. 1985;139:766-770.
62. Feder HM Jr. Comparative tolerability of anipicillin. amoxicillin, and trimethoprim-sulfamethoxazole suspensions in children with otitis media. Antimicrob Agents Chemother. 1982;21:426-427.
63. Feldman W, Momy J, Dulberg C. Trimethoprim-sulfamethoxazole vs. amoxicillin in the treatment of acute otitis media. Can Med Assoc J. 1988;139: 961-964.
64. Cooper J, Inman JS, Dawson AF. A comparison between co-trimoxazole and amoxicillin in the treatment of acute otitis media in general practice. Practitioner. 1976;217:804-809.
65. Hyams JS, Feder HM Jr, Krause PJ, et al. Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young children. Pediatr Infect Dis J. 1984;3: 433-436.
66. Gaskins JD, Holt RJ, Kyong CU, et al. Chemoprophylaxis of recurrent otitis media using trimethoprim/sulfamethoxazole. Drug Intell Clin Pharm. 1982;16: 387-390.
67. Ontario Drug Benefit Formulary. No. 34. Toronto, Ontario: Ministry of Health, 1994.
68. Schedule of Benefits, Physicians Services under the Health Insurance Act. Toronto. Ontario: Ministry of Health, 1994.
69. Drummond MF, Stoddart GL. Torrance GW. Cost-utility analysis. In: Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford Medical Publications; 1987:112-148.